Results 191 to 200 of about 67,862 (241)

The Effects of <i>BRCA1</i> and <i>BRCA2</i> Promoter Methylation on Clinicopathological Characteristics and Clinical Outcomes in HGSOC. [PDF]

Cells
Živić K, Boljević I, Nedeljković M, Matović M, Janković R, Tanić M.   +5 more
europepmc   +1 more source

Hormone Therapy After Oophorectomy and Breast Cancer Risk in Women With BRCA Pathogenic Variant.

JAMA Netw Open
Regev-Sadeh S, Michaelson-Cohen R, Madorksy-Feldman D, Friedman E, Armon S, Qarawani A, Srebnik N, Haddad J, Eisenberg VH, Segev Y.   +9 more
europepmc   +1 more source

Disease- and gene-specific deep learning for pathogenicity prediction of rare missense variants in cancer predisposition genes. [PDF]

BioData Min
Lee DB, Kang HU, Hwang KB.
europepmc   +1 more source

Rare genetic diseases associated with G-quadruplex-induced replication stress. [PDF]

Commun Biol
Herr LM, Mukhopadhyay S, Anderson OM, Couch TH, Jones CM, Brosh RM, Rossi M.   +6 more
europepmc   +1 more source

A novel cancer gene therapy achieving reciprocal regulation of PTEN and PARP1 expression. [PDF]

Mol Ther Oncol
Otsuka Y, Watanabe T, Kudo M.
europepmc   +1 more source

Frequency of Founder Mutations in <i>BRCA1</i> and <i>BRCA2</i> Genes in Hereditary Breast Cancers in Poland vs. Other Countries. [PDF]

Cancers (Basel)
Kulikowska B, Panasiuk B, Posmyk R.
europepmc   +1 more source

Functional analysis of BRCA1 and BRCA2 splicing variants using a minigene assay. [PDF]

Hum Genomics
Yim H, Youn S, Chae SW, Kim Y, Jang J, Cho SI, Lee JS, Seong MW.   +7 more
europepmc   +1 more source

Patenting the Fingerprint of God: How Gene Patents Violate the Products of Nature Doctrine [PDF]

, 2015
Todd, Timothy M.
core   +1 more source

A report of novel inactivating missense mutations of BRCA1 detected in patients with acute myeloid leukemia. [PDF]

J Med Case Rep
Ejaz S, Raashid A, Hameed Y, Abdullah I, Imtiaz N, Iqbal M, Khurshid M, Malik WN.   +7 more
europepmc   +1 more source